Patents by Inventor Marja-Liisa Karjalainen-Lindsberg

Marja-Liisa Karjalainen-Lindsberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of a patient subjected to thrombolyses
    Patent number: 8163734
    Abstract: The invention concerns the use of a mast cell activation- or degranulation-blocking agent in the manufacture of a medicament for preventing and treating cerebral complications caused by thrombolytic treatment. The invention also relates to treatment of patients suffering from cerebral complications associated with thrombolysis. Further, the invention provides thrombolytic compositions comprising a mast cell degranulation-blocking and/or mast cell activation-blocking agent present in a therapeutically effective amount to prevent or reduce any cerebral complications caused by the active thrombolytic component.
    Type: Grant
    Filed: February 13, 2004
    Date of Patent: April 24, 2012
    Inventors: Perttu J. Lindsberg, Marja-Liisa Karjalainen-Lindsberg, Turgut Tatlisumak, Daniel Strbian, Petri Kovanen
  • Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of cerebral ischemia
    Publication number: 20060276455
    Abstract: The invention concerns the use of a mast cell activation- or degranulation-blocking agent in the manufacture of a medicament for the treatment of cerebral ischemia. The invention also relates to treatment of patients suffering from acute ischemic stroke, acute hemorrhagic stroke, subarachnoid hemorrhage, cerebral venous thrombosis or global cerebral ischemia associated with cardiac arrest. Further, the invention provides compositions of contrast media or similar exogenous media, which are intended for use in diagnostic or therapeutic applications for introduction into the intravascular, intrathecal or the intracranial space, comprising a mast cell degranulation-blocking and/or mast cell activation-blocking agent.
    Type: Application
    Filed: February 13, 2004
    Publication date: December 7, 2006
    Inventors: Perttu Lindsberg, Marja-Liisa Karjalainen-Lindsberg, Turgut Tatlisumak, Daniel Strbian
  • Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of a patient subjected to thrombolyses
    Publication number: 20060210551
    Abstract: The invention concerns the use of a mast cell activation- or degranulation-blocking agent in the manufacture of a medicament for preventing and treating cerebral complications caused by thrombolytic treatment. The invention also relates to treatment of patients suffering from cerebral complications associated with thrombolysis. Further, the invention provides thrombolytic compositions comprising a mast cell degranulation-blocking and/or mast cell activation-blocking agent present in a therapeutically effective amount to prevent or reduce any cerebral complications caused by the active thrombolytic component.
    Type: Application
    Filed: February 13, 2004
    Publication date: September 21, 2006
    Inventors: Perttu Lindsberg, Marja-Liisa Karjalainen-Lindsberg, Turgut Tatlisumak, Daniel Strbian, Petri Kovanen